三星医疗(601567) - 2014 Q1 - 季度财报
SANXINGSANXING(SH:601567)2014-04-21 16:00

Financial Performance - Operating revenue decreased by 10.32% to CNY 418,569,200.93 compared to the same period last year[10] - Net profit attributable to shareholders increased by 7.62% to CNY 32,008,332.72 compared to the same period last year[10] - Basic and diluted earnings per share increased by 14.29% to CNY 0.08 compared to the same period last year[10] - Total operating revenue for the current period was ¥418,569,200.93, a decrease of 10.3% compared to ¥466,727,693.85 in the previous period[28] - Net profit for the current period increased to ¥32,078,659.55, up 7.5% from ¥29,742,012.46 in the previous period[28] - Basic and diluted earnings per share rose to ¥0.08, compared to ¥0.07 in the previous period, reflecting a 14.3% increase[29] - Total comprehensive income for the current period was ¥31,528,557.97, an increase of 6.0% from ¥29,742,012.46[29] Cash Flow - Net cash flow from operating activities was negative at CNY -240,171,470.82, compared to CNY -172,585,641.46 in the same period last year[10] - Cash flow from operating activities showed a net outflow of ¥240,171,470.82, worsening from a net outflow of ¥172,585,641.46 in the previous period[33] - Cash inflow from investment activities was ¥963,329,454.80, compared to ¥410,921,586.05 in the previous period, indicating a significant increase[34] - Cash outflow for investment activities totaled ¥964,972,904.58, up from ¥719,700,034.06, leading to a net cash outflow of ¥1,643,449.78[34] - Cash inflow from investment activities rose to $767.58 million from $410.92 million, an increase of approximately 87% year-over-year[37] - Net cash flow from investment activities improved to -$199.13 million from -$265.57 million, indicating a smaller deficit[37] Assets and Liabilities - Total assets increased by 2.96% to CNY 3,849,031,148.87 compared to the end of the previous year[10] - Total current assets decreased from CNY 2,325,222,389.17 at the beginning of the year to CNY 2,095,888,152.89, a decline of approximately 9.9%[19] - Total liabilities increased from CNY 1,499,413,019.03 to CNY 1,578,549,158.43, an increase of about 5.7%[21] - Total assets rose from CNY 3,738,366,451.50 to CNY 3,849,031,148.87, reflecting an increase of approximately 3.0%[21] - Total equity attributable to shareholders increased from CNY 2,237,450,141.96 to CNY 2,268,908,373.10, an increase of about 1.4%[21] Shareholder Information - The total number of shareholders reached 16,915 as of the report date[12] - The largest shareholder, Aux Group Co., Ltd., holds 44.94% of the shares, totaling 180,000,000 shares[12] - There were no violations of commitments made by major shareholders during the reporting period[15] Other Financial Metrics - The weighted average return on net assets increased by 0.08 percentage points to 1.40% compared to the same period last year[10] - Long-term receivables surged from CNY 283,092,152.20 to CNY 607,939,745.24, marking a significant increase of about 114.5%[20] - Inventory increased from CNY 308,551,926.86 to CNY 324,154,227.40, a rise of approximately 5.0%[19] - Accounts receivable increased from CNY 582,704,010.28 to CNY 667,854,332.91, representing a growth of about 14.6%[19] - Other receivables increased from CNY 53,949,453.08 to CNY 102,366,433.01, a growth of approximately 89.8%[19] Cash Management - Cash and cash equivalents slightly decreased from CNY 764,900,847.97 to CNY 762,003,959.39, a decrease of approximately 0.4%[19] - Cash and cash equivalents at the end of the period decreased to ¥629,365,846.53 from ¥857,436,737.79, a decline of 26.5%[35] - The ending cash and cash equivalents balance decreased to $149.76 million from $455.67 million, a decline of about 67.1% year-over-year[38]